US Stock MarketDetailed Quotes
VKTX Viking Therapeutics
- 52.860
- +1.230+2.38%
Trading Nov 22 14:09 ET
5.89BMarket Cap-56234P/E (TTM)
53.520High51.950Low1.71MVolume53.070Open51.630Pre Close90.11MTurnover1.63%Turnover RatioLossP/E (Static)111.44MShares99.41052wk High6.46P/B5.54BFloat Cap11.54552wk Low--Dividend TTM104.78MShs Float99.410Historical High--Div YieldTTM3.04%Amplitude0.880Historical Low52.679Avg Price1Lot Size
About Viking Therapeutics Company
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
Company Profile
SymbolVKTX
Company NameViking Therapeutics
Listing DateApr 29, 2015
Issue Price8.00
Founded2012
CEODr. Brian Lian, PhD
MarketNASDAQ
Employees27
Fiscal Year Ends12-31
Address9920 Pacific Heights Boulevard,Suite 350
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-704-4660
Company Executives
- Name
- Position
- Salary
- Dr. Brian Lian, PhD
- President, Chief Executive Officer and Director
- 12.63M
- Marianne Mancini
- Chief Operating Officer
- 3.51M
- Greg S. Zante
- Chief Financial Officer and Principal Accounting Officer
- 3.50M
- Dr. S. Kathryn Rouan, PhD
- Independent Director
- 178.65K
- Charles A. Rowland, Jr,M.B.A.
- Independent Director
- 189.62K
- Matthew W. Foehr
- Independent Director
- 169.37K
- J. Matthew Singleton
- Independent Director
- 192.77K
- Dr. Lawson Macartney, D.V.M.,PhD
- Chairperson of the Board
- 222.72K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
